About DaVita, Inc. 
DaVita, Inc.
Pharmaceuticals & Biotechnology
DaVita Inc., formerly DaVita HealthCare Partners Inc., operates one division: DaVita Kidney Care (Kidney Care). The Kidney Care division consists of the Company's United States dialysis and related lab services, its ancillary services and strategic initiatives, including its international operations, and its corporate administrative support. The Company's segments include U.S. dialysis and related lab services and Other-Ancillary services and strategic initiatives. Its U.S. dialysis and related lab services line of business provide kidney dialysis services in the United States for patients suffering from chronic kidney failure, also known as an end-stage renal disease (ESRD). In addition, as of March 31, 2019, the Company operated or provided administrative services to 243 outpatient dialysis centers located in nine countries outside of the United States.
Company Coordinates 
Company Details
2000 16th St , DENVER CO : 80202-5158
Registrar Details
Shareholding Snapshot
Shareholding Compare (%holding) 
Majority shareholders
Domestic Funds
Domestic Funds
Held in 115 Schemes (20.47%)
Foreign Institutions
Held by 317 Foreign Institutions (11.2%)
Strategic Entities with highest holding
Highest Public shareholder
Management
Designation
Ms. Pamela Arway
Independent Chairman of the Board
Mr. Javier Rodriguez
Chief Executive Officer, Director
Mr. Charles Berg
Director
Mr. Shawn Guertin
Director
Ms. Barbara Desoer
Independent Director
Mr. Paul Diaz
Independent Director
Mr. John Nehra
Independent Director
Revenue and Profits:
Net Sales:
3,380 Million
(Quarterly Results - Jun 2025)
Net Profit:
275 Million
Pharmaceuticals & Biotechnology
USD 10,660 Million (Small Cap)
10.00
NA
0.00%
-26.14
-296.97%
-28.84






